Detalles de la búsqueda
1.
Research Progress on Molecular Diagnosis and Individualized Treatment for Malignant Lymphoma / 肿瘤防治研究
Cancer Research on Prevention and Treatment
; (12): 1165-1173, 2023.
Artículo
en Zh
| WPRIM | ID: wpr-1003795
2.
Immunosuppressive tumor microenvironment contributes to tumor progression in diffuse large B-cell lymphoma upon anti-CD19 chimeric antigen receptor T therapy / 医学前沿
Frontiers of Medicine
; (4): 699-713, 2023.
Artículo
en Inglés
| WPRIM | ID: wpr-1010796
3.
PD-1/PD-L1 and CTLA-4 monoclonal antibodies: gastrointestinal toxicity and treatment / 中华微生物学和免疫学杂志
Chinese Journal of Microbiology and Immunology
; (12): 794-799, 2019.
Artículo
en Zh
| WPRIM | ID: wpr-796609
4.
PD-1 / PD-L1 and CTLA-4 monoclonal antibodies: gastrointestinal toxicity and treatment / 中华微生物学和免疫学杂志
Chinese Journal of Microbiology and Immunology
; (12): 794-799, 2019.
Artículo
en Zh
| WPRIM | ID: wpr-792040
5.
Progress of immune checkpoint inhibitors in treatment of malignant lymphoma / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
; (12): 709-712, 2019.
Artículo
en Zh
| WPRIM | ID: wpr-800704
6.
Prognostic evaluation of P53 and BCL2 proteins in MYC/BCL2 double expression DLBCL / 中华血液学杂志
Chinese Journal of Hematology
; (12): 589-593, 2019.
Artículo
en Zh
| WPRIM | ID: wpr-805659
7.
Progress of chimeric antigen receptor T-cell for treatment of malignant lymphoma / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
; (12): 4-7, 2018.
Artículo
en Zh
| WPRIM | ID: wpr-691596
8.
Mechanisms of resistance to cancer immunotherapy / 中华微生物学和免疫学杂志
Chinese Journal of Microbiology and Immunology
; (12): 874-878, 2017.
Artículo
en Zh
| WPRIM | ID: wpr-666281
9.
CTLA-4 and PD-1:the potential immunotherapeutic targets for malignant lymphoma / 中华微生物学和免疫学杂志
Chinese Journal of Microbiology and Immunology
; (12): 783-789, 2016.
Artículo
en Zh
| WPRIM | ID: wpr-501508
10.
Analysis of clinical features and prognosis of 27 patients with mantle cell lymphoma / 天津医药
Tianjin Medical Journal
; (12): 1128-1131, 2016.
Artículo
en Zh
| WPRIM | ID: wpr-498758
11.
Prognosis and staging of primary bone lymphoma:an analysis of 40 patients / 中华放射肿瘤学杂志
Chinese Journal of Radiation Oncology
; (6): 843-846, 2016.
Artículo
en Zh
| WPRIM | ID: wpr-495526
12.
Clinical analysis of Hyper-CVAD/MA regimen and CHOP/CHOP-like regimen in the treatment of 78 patients with peripheral T-cell lymphoma, not otherwise specified (PT-CL-NOS) / 中国肿瘤临床
Chinese Journal of Clinical Oncology
; (24): 486-492, 2016.
Artículo
en Zh
| WPRIM | ID: wpr-490337
13.
Clinical decision on a patient with ALK+diffuse large B cell lymphoma / 中国肿瘤临床
Chinese Journal of Clinical Oncology
; (24): 385-391, 2016.
Artículo
en Zh
| WPRIM | ID: wpr-494347
14.
miR-10a inhibits cell proliferation and promotes cell apoptosis by targeting BCL6 in diffuse large B-cell lymphoma
Protein & Cell
; (12): 899-912, 2016.
Artículo
en Inglés
| WPRIM | ID: wpr-757360
15.
Application of precision medicine in non-small cell lung cancer / 国际生物医学工程杂志
International Journal of Biomedical Engineering
; (6): 247-252, 2015.
Artículo
en Zh
| WPRIM | ID: wpr-480689
16.
A long-term follow-up study on the treatment of small cell lung cancer using teniposide/carboplatin with etoposide/carboplatin as first-line therapy / 天津医药
Tianjin Medical Journal
; (12): 788-791, 2015.
Artículo
en Zh
| WPRIM | ID: wpr-461821
17.
Efficacy of bendamustine hydrochloride in patients with rituximab-refractory indolent B-cell non-Hodgkin's lymphoma:results from a phaseⅢmulticenter study / 中国肿瘤临床
Chinese Journal of Clinical Oncology
; (24): 1025-1030, 2015.
Artículo
en Zh
| WPRIM | ID: wpr-481311
18.
Mechanisms of histone deacetylase inhibitor in treating T-cell lymphoma and related clinical trials / 中国肿瘤临床
Chinese Journal of Clinical Oncology
; (24): 1213-1216, 2014.
Artículo
en Zh
| WPRIM | ID: wpr-471567
19.
Research progress into Castleman disease / 中国肿瘤临床
Chinese Journal of Clinical Oncology
; (24): 1135-1139, 2014.
Artículo
en Zh
| WPRIM | ID: wpr-456670
20.
Molecular mechanism of synergistic antitumor activity and induced apoptosis of zoledronic acid and paclitaxel / 中国肿瘤临床
Chinese Journal of Clinical Oncology
; (24): 60-63, 2014.
Artículo
en Zh
| WPRIM | ID: wpr-440194